Novartis AG (NVS)
94.37
+1.80
(+1.94%)
USD |
NYSE |
Apr 19, 16:00
94.36
-0.02
(-0.02%)
After-Hours: 17:35
Novartis Gross Profit (Quarterly): 8.754B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.754B |
September 30, 2023 | 8.975B |
June 30, 2023 | 9.595B |
March 31, 2023 | 9.277B |
December 31, 2022 | 7.925B |
September 30, 2022 | 7.909B |
June 30, 2022 | 9.334B |
March 31, 2022 | 8.958B |
December 31, 2021 | 4.775B |
September 30, 2021 | 9.429B |
June 30, 2021 | 9.38B |
March 31, 2021 | 8.655B |
December 31, 2020 | 8.813B |
September 30, 2020 | 8.785B |
June 30, 2020 | 8.193B |
March 31, 2020 | 8.986B |
December 31, 2019 | 8.724B |
September 30, 2019 | 8.706B |
June 30, 2019 | 8.618B |
March 31, 2019 | 8.204B |
December 31, 2018 | 7.859B |
September 30, 2018 | 7.923B |
June 30, 2018 | 8.095B |
March 31, 2018 | 7.712B |
December 31, 2017 | 5.486B |
Date | Value |
---|---|
September 30, 2017 | 8.369B |
June 30, 2017 | 8.236B |
March 31, 2017 | 7.68B |
December 31, 2016 | 8.117B |
September 30, 2016 | 7.973B |
June 30, 2016 | 8.228B |
March 31, 2016 | 7.598B |
December 31, 2015 | 8.255B |
September 30, 2015 | 8.097B |
June 30, 2015 | 8.409B |
March 31, 2015 | 8.222B |
December 31, 2014 | 8.938B |
September 30, 2014 | 8.879B |
June 30, 2014 | 9.571B |
March 31, 2014 | 8.901B |
December 31, 2013 | 9.20B |
September 30, 2013 | 8.78B |
June 30, 2013 | 9.193B |
March 31, 2013 | 9.60B |
December 31, 2012 | 7.281B |
September 30, 2012 | 9.464B |
June 30, 2012 | 9.931B |
March 31, 2012 | 9.429B |
December 31, 2011 | 9.878B |
September 30, 2011 | 10.25B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
4.775B
Minimum
Dec 2021
9.595B
Maximum
Jun 2023
8.621B
Average
8.785B
Median
Sep 2020
Gross Profit (Quarterly) Benchmarks
Sandoz Group AG | -- |
Amgen Inc | 5.084B |
AstraZeneca PLC | 9.716B |
Incyte Corp | 943.54M |
MorphoSys AG | 47.84M |